1-Piperidinepropanenitrile, α-[1-amino-3-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-3-oxopropylidene]-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-
|
|
1-Piperidinepropanenitrile, α-[1-amino-3-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-3-oxopropylidene]-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)- 속성
- 밀도
- 1.367±0.06 g/cm3(Predicted)
- 산도 계수 (pKa)
- 13.30±0.50(Predicted)
안전
1-Piperidinepropanenitrile, α-[1-amino-3-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-3-oxopropylidene]-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)- C화학적 특성, 용도, 생산
1-Piperidinepropanenitrile, α-[1-amino-3-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-3-oxopropylidene]-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)- 준비 용품 및 원자재
원자재
준비 용품
1-Piperidinepropanenitrile, α-[1-amino-3-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-3-oxopropylidene]-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)- 공급 업체
글로벌( 4)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd | 15850510341 |
shiqingran@wzxchem.com | China | 3621 | 58 |
Nanjing Huanuo Biomedical Technology Co., Ltd | 18913906212 |
2885426135@qq.com | China | 6789 | 58 |
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd | 18102736234 18102736234 |
2208093734@qq.com | China | 7256 | 58 |
1-Piperidinepropanenitrile, α-[1-amino-3-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-3-oxopropylidene]-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)- 관련 검색:
2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine
4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE
Ethanone, 2-methoxy-1-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Tofacitinib Impurity 85
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
4-Amino-2,6-dichloropyrimidine
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
2-Chloro-3,7-dihydro-4H-pyrrolo[2,3-d]pyriMidin-4-one
Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 2-chloro-N-methyl-7-[(4-methylphenyl)sulfonyl]-N-[(3R,4R)-4-methyl-3-piperidinyl]-
Tofacitinib Impurity 29
Tofacitinib Impurity 2
(1-Benzyl-4-Methyl-1,2,5,6-tetrahydropyridin-3-yl)carbaMic acid Methyl ester